Post

New research · Urology
Veterinary research communications · 17h
Animal / preclinicalVeterinary research communications · 2026

Antimicrobial resistance profiles of bacterial pathogens from feline urinary tract infections in Rio de Janeiro, Brazil.

Barbara Barreto Oliveira, Camila Alves Maia da Silva, Izabella Brito de Souza … Mariana Severo Ramundo
Read paper
UrologyAnimal / preclinical

Over half of feline urinary tract infection isolates were multidrug-resistant.

Antimicrobial resistance profiles of bacterial pathogens from feline urinary tract infections in Rio de Janeiro, Brazil.

Barbara Barreto Oliveira et al. · Veterinary research communications · 2026
Purpose

This study characterized the bacterial epidemiology and antimicrobial resistance profiles of 448 isolates recovered from feline urine cultures in Rio de Janeiro, Brazil, between 2020 and 2024.

Results

Multidrug resistance found in more than half of cat urine bacteria, limiting treatment options.

79.5%
Proteus spp.
57.9%
E. coli
More results

Escherichia coli was the predominant pathogen (45.1%), followed by Proteus spp.

Resistance to antimicrobials recommended as first-line options by the ISCAID guidelines was frequent among E. coli isolates, including trimethoprim-sulfamethoxazole (57.2%), cephalexin (52.5%), and amoxicillin-clavulanate (43.9%).

More results

Veterinary fluoroquinolones showed moderate resistance (enrofloxacin 28.5%, marbofloxacin 20.9%), while nitrofurantoin resistance reached 37.7%.

Third-generation cephalosporins and carbapenems retained the highest activity (ceftazidime 13.2%; meropenem 0%).

“
Conclusion

These findings indicate that resistance to first-line agents is common in feline uropathogens in this setting and support the routine use of urine culture and antibiotic susceptibility testing to guide antimicrobial therapy.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
HR 1.87
lower muscle quality means nearly twice the risk of dying from advanced prostate cancer
Cross-sectional
71.8%
most urologists never used a standard survey to assess stent symptoms
Cohort Study
SIR 1.67
young bladder cancer survivors have a higher risk of developing second cancers compared to the general population
Cohort Study
98%
98% of patients had no significant rectocele after laparoscopic double sacrocolpopexy.
Cohort Study
OR 0.10
Beyond 4000 J/ml, the odds of reintervention are 90% lower.
Randomized Trial
hazard ratio 0·67
pirarubicin instillation led to a lower risk of recurrence compared to observation
Study
3,216
This many specific enhancers were found in prostate cancer cells, not normal cells.
Case-control
OR = 4.23
Higher triglycerides linked to higher odds of prostate cancer (odds, not risk)